GLP-1(7-37)

GLP-1(7-37), also known as glucagon-like peptide-1 (7-37), is a biologically active peptide fragment derived from the proglucagon precursor. As a member of the incretin hormone family, it plays a central role in modulating glucose metabolism and insulin secretion through its interaction with the GLP-1 receptor. The molecule's potent effects on pancreatic beta cells and its involvement in gut-brain axis signaling have made it a focal point in metabolic and endocrinological research. Its ability to influence multiple physiological pathways underscores its importance as a research tool for elucidating complex regulatory mechanisms in energy homeostasis and nutrient sensing.

Peptide signaling studies: GLP-1(7-37) is widely utilized in studies investigating peptide-mediated signal transduction, specifically those related to the activation of the GLP-1 receptor. By serving as a highly selective agonist, it enables researchers to dissect the downstream effects of GLP-1 receptor engagement, including modulation of cyclic AMP levels, activation of protein kinase A, and the regulation of intracellular calcium dynamics. These studies are critical for mapping the molecular cascades underlying insulinotropic responses and for understanding the broader physiological roles of peptide hormones.

Metabolic pathway research: The peptide is frequently employed as a reference standard in experiments focused on glucose-stimulated insulin secretion and metabolic regulation. Its well-characterized biological activity provides a reliable tool for probing the mechanisms by which incretin hormones modulate pancreatic function, hepatic glucose output, and peripheral tissue glucose uptake. By incorporating GLP-1(7-37) into metabolic assays, investigators can quantitatively assess the contributions of incretin signaling to overall glucose homeostasis, facilitating the identification of novel targets within metabolic pathways.

Peptide-receptor interaction analysis: GLP-1(7-37) serves as a model ligand in the characterization of peptide-receptor binding dynamics and affinity studies. Its defined sequence and receptor specificity make it ideal for kinetic and structural analyses, including radioligand binding assays, surface plasmon resonance experiments, and computational docking studies. Through these approaches, researchers can elucidate the molecular determinants of receptor activation, ligand selectivity, and signal transduction efficiency, which are essential for guiding the rational design of receptor modulators.

Cellular signaling pathway elucidation: Researchers utilize GLP-1(7-37) to explore the downstream effects of incretin signaling in various cell types, including pancreatic islets, neuronal populations, and gastrointestinal tissues. By applying the peptide in vitro or ex vivo, scientists can monitor changes in gene expression, protein phosphorylation states, and cellular secretory responses. These investigations provide mechanistic insight into the cross-talk between metabolic, neural, and endocrine systems, expanding our understanding of the integrative physiology governed by peptide hormones.

Peptide analog development: The well-defined structure and biological activity profile of GLP-1(7-37) make it a valuable template for the design and synthesis of novel peptide analogs and mimetics. Researchers leverage its sequence to generate modified peptides with altered receptor affinity, enhanced stability, or tailored pharmacodynamic properties for experimental purposes. Such analogs are instrumental in structure-activity relationship studies, enabling the systematic evaluation of residue contributions to receptor binding and biological function, and supporting the advancement of next-generation peptide-based research tools.

1. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I